2003N-0059 - Pharmaceutical Current Good Manufacturing Practices for the 21st Century: A Risk- Based Approach

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC38
  



  

  

  


  

  



  

  
Submitter : 
  

  
Mr. Hurmat Hussain
  

  
Date & Time: 
  

  
09/12/2003 05:09:36
  



  

  
Organization : 
  

  
Eli Lilly
  



  

  
Category : 
  

  
Drug Industry
  



  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
Would like to see the risk based GMP